Clinical Trial Update: Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

View source ↗

Summary

A completed clinical trial assessing the biodistribution and pathophysiology of the radiotracer 18F-FDS in diseased patients. The study encompassed enterobacter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Enterobacterial Infections
• Inflammatory Diseases
• Invasive Fungal Infections

Drugs mentioned

• 18F-Fluorodeoxysorbitol (18F-FDS)

Snippet

Sponsor: Johns Hopkins University | Conditions: Enterobacterial Infections, Oncologic Disease | Status: COMPLETED